|
EP3785699A1
|
|
Composition of n-palmitoyl-ethanolamide and rutin in co-micronized form
|
|
US2019290609A1
|
|
Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine
|
|
ITUB20154849A1
|
|
ADELMIDROL FOR USE IN PATHOLOGIES CHARACTERIZED BY INSUFFICIENT AGONISM OF THE PPAR-gamma RECEPTOR
|
|
EP2985037A1
|
|
A pharmaceutical composition comprising palmitoylethanolamid and cytidine-diphosphocholine
|
|
HUE044915T2
|
|
Use of palmitoylethanolamide in combination with opioids
|
|
EP2921167A1
|
|
Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine
|
|
HUE047471T2
|
|
Ophthalmic, intra-articular or intravesical preparations containing N-acyl-ethanolamines
|
|
EP2821083A1
|
|
Combined use of amides of mono- and dicarboxylic acids and silymarin in the treatment of renal diseases
|
|
EP2742957A1
|
|
Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides
|
|
EP2455066A1
|
|
Pharmacological preparation for topical use containing N-palmitoyl-vanillamide
|
|
EP2444078A1
|
|
Use of amides of mono and dicarboxylic acids in the treatment of renal diseases
|
